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1  | INTRODUC TION
Long- term implant success occurs only when implants are 
placed in biologically and prosthetically favorable positions; 
alveolar ridge deficiencies impede meeting these requirements 
(Buser et al., 2017; Mailoa et al., 2017). Extensive bone and soft 
tissue defects result from periodontal disease, trauma, or other 
pathologies (Hammerle & Tarnow, 2018). While block grafting had 
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Abstract
Objective: To clinically evaluate the use of a titanium- reinforced PTFE mesh for verti-
cal bone augmentation (VBA) of deficient alveolar ridges.
Materials and methods: This case series documented consecutive patients treated 
for VBA with a newly developed PTFE mesh. VBA was performed in anterior and 
posterior, maxillary and mandibular arches using anorganic bovine bone combined 
with autogenous graft in a 1:1 ratio. Healing time from initial surgery to re- opening 
was recorded. Baseline vertical deficiency, absolute bone gain (gross height gained), 
and relative gain (percentage of defect fill with respect to the baseline deficiency) 
were registered.
Results: Fifty- seven patients (65 defects) were included in the analysis. The mean 
baseline vertical deficiency was 5.5 ± 2.6 mm. The mean absolute bone gain was 
5.2 ± 2.4 mm. A relative gain of 96.5 ± 13.9% was achieved. Overall, 89.2% of cases 
showed complete regeneration, which occurred in all sites with baseline deficien-
cies of <5 mm, in 95.6% of sites with 5– 8 mm deficiencies, and in 89.4% of sites 
with >8 mm deficiencies. Each 1- mm addition to the baseline height deficiency in-
creased the likelihood of incomplete bone regeneration by 2.5 times. Defect location 
had a statistically significant but a limited clinical impact on the bone height gained 
(<0.5 mm). Complications were observed in three cases (3%).
Conclusions: Vertical bone augmentation with titanium- reinforced PTFE mesh and a 
mixture of autologous bone and xenograft is a safe and predictable procedure. The 
extent of the baseline vertical deficiency influences the percentage of bone gained.
K E Y W O R D S
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been considered the optimal treatment to correct hard tissue de-
ficiencies, guided bone regeneration (GBR) was found to generate 
results on par with block grafting (Milinkovic & Cordaro, 2014). A 
systematic review and meta- analysis on vertical bone augmenta-
tion (VBA) concluded that GBR using barrier membranes produced 
comparable bone gain and fewer postoperative complications 
compared with block grafting (Urban et al., 2019). Though, other 
reviews have demonstrated the superior results for block grafting 
(Chiapasco & Casentini, 2018) and higher complication rates for 
GBR (Chiapasco & Zaniboni, 2009).
Autologous bone remains the gold standard material for grafting 
due to its osteogenic, osteoinductive, and osteoconductive charac-
teristics but is quantitatively limited, resorbs faster, and frequently 
requires a second donor site relative to other graft types (Cordaro 
et al., 2002; Papageorgiou et al., 2016; Sbordone et al., 2009). 
Supplementing particulate autogenous bone with anorganic bo-
vine bone- derived mineral (ABBM) significantly slows the rate of 
graft resorption and requires less autogenous harvesting (Maiorana 
et al., 2005; Wen et al., 2018). Combining graft types is an efficient 
approach for ridge regeneration.
Guided bone regeneration uses barrier membranes to create 
space above the bony defect and subperiosteally and to exclude 
faster- migrating connective tissue and epithelial cells, giving osteo-
progenitor cells the space and time necessary to colonize and fill with 
bone the surgically constructed area (Polimeni et al., 2006). Occlusive 
membranes, however, may decelerate angiogenesis, as vessels from 
the subperiosteum are blocked by the barrier, permitting revascular-
ization mainly from the residual ridge (Wang & Boyapati, 2006). VBA 
is particularly demanding biologically since osteogenesis and angio-
genesis rely only on basal bone, outside any bony envelope.
Studies have demonstrated predictable results with GBR using 
non- resorbable membranes that remain unexposed (Machtei, 2001; 
Nowzari & Slots, 1995). Non- resorbable membranes mandate re-
moval, which is a non- issue when pre- implantation GBR is planned 
but a drawback when GBR simultaneous to implant placement 
occurs. Absorbable membranes do not necessitate removal and 
are clinically effective and cell compatible; as such, they are pre-
ferred by many clinicians (Jung et al., 2013; Rothamel et al., 2004). 
However, some systematic reviews have reported that absorbable 
membranes are more complication- prone than non- resorbable 
ones, particularly in terms of membrane exposure (Elnayef 
et al., 2018; Lim et al., 2018; Urban et al., 2019). The major con-
cern with absorbable membranes is that they maintain space less 
well than non- absorbable barriers because they lack form stability, 
which leads to graft migration, membrane collapse, and insuffi-
cient bone formation (McGinnis et al., 1998). A systematic review 
has also shown that the success rates of implants placed in ridges 
regenerated with titanium mesh were comparable to those of im-
plants placed in native bone, and of implants placed in bone regen-
erated with either absorbable or non- resorbable membranes (Ricci 
et al., 2013). Long- term follow- up for implants after VBA using 
titanium mesh also demonstrated high survival rates (Roccuzzo 
et al., 2017).
Our group has shown that using titanium- reinforced dPTFE mem-
branes with a mixture of autologous bone and xenograft produce sat-
isfactory VBA outcomes (Urban et al., 2014, 2015). A hybrid structure 
combining classic titanium mesh and PTFE membrane features has been 
introduced (RPM™— Reinforced PTFE Mesh, Cytoplast®; Osteogenic 
Biomedical). This PTFE mesh is composed of circular macropores that 
allow direct communication between the surgically created space and 
the overlying periosteum, allowing the area to be more readily revas-
cularized and populated by progenitor cells per the manufacturer. The 
titanium frame of this structure maintains the space essential for VBA.
Regardless of the surgical approach, VBA may achieve approx-
imately 4 mm of vertical bone gain (Elnayef et al., 2018; Milinkovic 
& Cordaro, 2014; Urban et al., 2019). To date, we are not aware of 
any patient- based investigation on VBA using this hybrid PTFE mesh 
(RPM™). Our retrospective case series aims to clinically evaluate 
using a titanium- reinforced PTFE mesh to correct vertical ridge defi-
ciencies prior to implant placement and to assess factors influencing 
treatment outcomes.
1.1 | Primary study objectives
1. To evaluate the amount of bone height gain in millimeters and 
as a percentage of the baseline deficiency from VBA using 
a titanium- reinforced PTFE mesh with mixed autogenous and 
ABBM particulate grafts.
2. To examine the influence of defect location, baseline deficiency 
extent, and membrane exposure on augmentation height.
3. To report the incidence of surgical and post- surgical complica-
tions associated with this treatment.
2  | MATERIAL AND METHODS
Fifty- seven consecutive patients who had been treated using 
titanium- reinforced PTFE mesh with mixed autogenous and ABBM 
particulate grafts for pre- implantation VBA between August 2016 
and June 2019 were included for analysis. All patients were treated 
in one private practice (Urban Regeneration Institute, Budapest, 
Hungary). All VBA procedures were performed by the same expe-
rienced practitioner (IU). Implant placement and subsequent pros-
thetic treatments were performed by author IU or other private 
practitioners. This study was approved by the Institutional Review 
Board for Human Studies with the following code (118/2020- 
SZTE). Strengthening the Reporting of Observational Studies in 
Epidemiology (STROBE) guidelines were followed during the prepa-
ration of the manuscript.
2.1 | Inclusion and exclusion criteria
Included patients had vertical bone insufficiency that precluded 
stable dental implant placement or that would result in poor 
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crown- to- implant ratios or esthetic compromise. Participants were 
required to have good physical health and good oral hygiene prior to 
treatment (plaque index of <10%) (Silness & Loe, 1964).
Patients were not recruited if any of the following criteria were 
met:
1. Bone augmentation procedures not using titanium- reinforced 
PTFE mesh.
2. Heavy smokers (>10 cigarettes/day).
3. History of local radiation therapy within the previous 5 years.
4. Uncontrolled diabetes mellitus.
5. Alcoholism or chronic drug abuse.
6. Any uncontrolled medical conditions.
2.2 | Surgical procedure
Potential risks and benefits of VBA procedure were reviewed pre-
surgically with all enrolled patients. Written consent was obtained 
from all patients prior to surgery. All participants received prophy-
lactic systemic antibiotic coverage with 500 mg amoxicillin tid or, in 
the case of penicillin allergy, 150 mg clindamycin qid 24 hr prior to 
surgery.
A mid- crestal incision was made in the keratinized mucosa of 
the edentulous site to be augmented, and sulcular incisions were 
made around adjacent teeth. Periosteal elevators were used to 
raise full- thickness mucoperiosteal flaps extending at least 5 mm 
apical to the alveolar crest; particular care was given to sites with 
thin mucosa or minimal to no keratinized tissue to avoid flap per-
foration. To enhance access, two vertical releasing incisions were 
made at least one tooth away from the surgical site. The depth and 
location of the vertical releasing incisions, as well as the technique 
used for flap management, depended on the depth of the ves-
tibule and the extent of the existing defect (Urban et al., 2016). 
For mandibular cases, lingual flaps were elevated to the mylohy-
oid muscle attachment, which was then bluntly separated (Urban 
et al., 2017).
Each recipient site was decorticated using a small round bur to 
increase blood supply to the recipient bed. A particulate autograft 
was harvested with a bone scraper from intraoral sites adjacent to 
the defect (Osteogenic Biomedical). The amount of bone harvested 
was based on the amount of graft needed. Autogenous bone partic-
ulate was mixed with ABBM (Bio- Oss, Geistlich Pharma, AG) in a 1:1 
ratio and positioned on the residual ridge to mimic the desired bony 
morphology.
The area to be covered by mesh was estimated using University 
of North Carolina- 15 probe (UNC- 15), and an appropriately sized 
titanium- reinforced PTFE mesh (RPM™) was selected, trimmed, 
and placed to completely cover the graft and at least 2 mm of ad-
jacent native bone. The mesh was stabilized on the lingual/palatal 
sides using titanium pins (Master Pin, Meisinger) or screws (Profix®, 
Osteogenics Biomedical) (Urban et al., 2016). The PTFE mesh was 
covered with a native collagen membrane (Bio- Gide, Geistlich 
Pharma, AG) without stabilization.
Periosteal releasing incisions were carefully made to advance 
buccal flaps. In premolar sites, the mental nerve was protected, 
particularly cases with severe atrophy that demanded more api-
cally extending vertical incisions. Lingual flaps were advanced 
based on the location of the mylohyoid muscle attachment and 
were handled according to three previously described zones of in-
terest (Urban et al., 2017). Double- layered suturing was employed 
to create intimate tissue adaptation and prevent membrane expo-
sure. In this technique, horizontal mattress sutures (GORE- TEX® 
CV- 5 Suture, W.L. Gore & Associates) were placed 4– 5 mm from 
the incision line. Then, single interrupted sutures were used to 
secure all flap edges. The sutures were left undisturbed for at 
least 2– 3 weeks. The surgical site was allowed to heal for at least 
6 months. At re- entry, limited mucoperiosteal flaps were ele-
vated to remove the PTFE mesh and titanium pins and/or screws 
and to perform implant placement. Figure 1 details the surgical 
procedure.
2.3 | Post- surgical procedures
A postoperative regimen of amoxicillin 500 mg tid for 7 days or, in 
the case of penicillin allergy, 150 mg clindamycin qid for 6 days was 
prescribed. A nonsteroidal anti- inflammatory drug (50 mg diclofenac 
potassium tid or ibuprofen 200 mg tid) was prescribed for 1 week 
following the surgery. All patients were evaluated at 1, 2 or 3, and 
4 weeks following surgery. Intra- operative and postoperative com-
plications such as membrane exposure, intra- operative bleeding, 
and graft infection were recorded.
2.4 | Data collection
Patient information including gender, age at the time of the sur-
gical treatment, and self- reported cigarette consumption was 
recorded. Intraoperatively, the extent of baseline vertical defi-
ciency was measured by one provider (I.U) in millimeters from the 
residual ridge crest to one reference line using a UNC- 15 probe. 
One of two reference lines was used to ensure consistent verti-
cal measurements and to serve as ideal heights: (a) an imaginary 
line connecting the interproximal bone height between adjacent 
teeth; or (b) in the case of distal edentulism, an imaginary line 
connecting the proximal tooth bone height to the projected non- 
resorbed alveolar crest of the edentulous area. The vertical bone 
gain was evaluated at the time of implant placement (re- entry) 
and measured in the same fashion as described above. The hori-
zontal distance between the site of measurement and the root 
surface/ non- resorbed alveolar crest of the nearest tooth was 
recorded to guarantee reproducible measurement in mesio- distal 
direction.
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Absolute gain was defined as the amount of bone gained in 
millimeters regardless of baseline vertical deficiency. Relative gain 
was defined as the percentage of the vertical deficiency that was 
resolved relative to the ideal height.
2.5 | Statistical analysis
Logistic regression using generalized estimation equations (GEE) was 
conducted to assess vertical bone gain differences and the probabil-
ity of complete relative bone gain according to positional variables. 
Models were adjusted for defect size, healing time, age, and smok-
ing; beta coefficients, odds ratio, and 95% confidence intervals (via 
Wald chi- square test) were calculated. The significance level was set 
as 5% (α = .05).
A post hoc power analysis determined that a sample size of 65 
independent sites provided 85.1% power with 95% confidence for 
detecting mean gains of 4.5 and 6.0 mm as significantly different 
using linear regression. However, as not all sites were independent, 
a power correction was necessary. Each patient provided a mean of 
1.14 sites, and a high within- subject correlation (CCI = 0.9) was as-
sumed, leading to a correcting coefficient of D = 1.13. Therefore, 65 




The sample included 57 patients (65 defects) who underwent VBA 
using titanium- reinforced PTFE mesh. Twenty- one males (36.8%) 
and 36 females (63.2%) with a mean age of 51.9 ± 11.8 years (range: 
28– 78 years) were included. Each patient received surgery in one 
(86%) or two different sites (14%). 96.5% of the patients were non- 
smokers; two patients were smokers. Demographic, clinical, and 
defect distribution characteristics are shown in Table 1; defect dis-
tribution is further described in Figure 2.
F I G U R E  1   Representative case from the current cohort with a step- by- step demonstration of the surgical procedure. (a) Panoramic 
radiograph showing a posterior mandibular area that required vertical GBR. The mental nerve approximated the residual ridge crest. (b) 
Buccal view showing the atrophic ridge preoperatively. (c) Titanium- reinforced PFTE mesh was fixed in place after decortication of recipient 
site; the size of the vertical defect was ≥12 mm. (d) Placement of particulate anorganic bovine bone combined with autogenous graft (1:1 
ratio). (e) Titanium- reinforced PFTE mesh fixed in place with titanium pins and screws. A coronal flap advancement of nearly 15 mm was 
obtained before closure. (f) Tension- free flap closure was performed using the double- layer suturing technique. (g) Clinical view of the 
regenerated bone. Note the excellent dimensions and vital- looking ridge. (h) Two implants in place in biologically and prosthetically ideal 
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3.2 | Bone gain analysis
Table 2 and Figure 3a,b document ridge height changes post- VBA. The 
mean baseline vertical deficiency was 5.5 ± 2.6 mm. The absolute gain 
in vertical dimension from VBA was 5.2 ± 2.4 mm, corresponding a 
mean relative height gain of 96.5 ± 13.9%; 89.2% of the sites presented 
complete regeneration, that is, elimination of vertical deficiency.
3.3 | Influence of baseline vertical deficiency on 
absolute and relative bone gain
Six defects out of 65 were not completely regenerated. Five of these 
sites had baseline vertical deficiencies of ≥10 mm (Figure 4a), and 
one site with a 6 mm baseline deficiency was infected postopera-
tively. The probability of having complete regeneration was inversely 
proportional to defect size (p = .005). Each 1- mm addition to base-
line height deficiency increased the likelihood of incomplete bone 
regeneration by 2.5 times. Having a baseline deficiency of 5– 8 mm 
reduced the relative gain by 6% compared with having a baseline 
deficiency <5 mm (p = .045). Having a baseline deficiency of >8 mm 
reduced the relative bone gain by 12% compared with having a base-
line deficiency <5 mm (p < .001) (Figure 4b). Multiple linear regres-
sion controlling for defect size, arch, healing time, and age (Table 3) 
TA B L E  1   Demographic and clinical characteristics of the studied 
cohort. Number of patients (%) or sites (%), mean ± standard 
deviation
N (%)/mean ± SD
Patient level
N patients 57













MAX anterior 12 (18.5)
MAX right posterior 11 (16.9)
MAX left posterior 6 (9.2)
MAN anterior 4 (6.2)
MAN right posterior 15 (23.1)














Defect size (mm) 5.5 ± 2.6
N of missing teeth 3.2 ± 1.2
Maxilla 3.1 ± 1.5
Mandible 3.2 ± 0.9
F I G U R E  2   Distribution of the defect (%) by site
F I G U R E  3   Absolute vertical gain (mm) and relative vertical gain 
(%) after vertical bone augmentation
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identified healing time to be a significantly affected vertical growth 
(p = .037). Each 1- month addition to healing time increased relative 
gain by 1.34%.
3.4 | Influence of defect location on absolute bone 
gain: maxilla versus mandible
There were 29 maxillary and 36 mandibular defects treated in this 
study. The baseline mean vertical deficiency was 5.3 ± 2.5 mm in the 
maxilla and 5.6 ± 2.7 mm in the mandible; there was no difference in 
this variable between the arches per GEE (p = .664). Mean absolute 
vertical bone gain was 5.1 ± 2.2 mm in the maxilla and 5.3 ± 2.6 mm 
in the mandible; there was no difference in this variable between the 
arches per multiple linear regression (p = .596) (Table 4). Defect size 
(p < .01) and healing time (p < .05) significantly affected vertical gain. 
Smoking was not statistically relevant (p = .220), but a large effect 
size (β = −1.60) was observed.
3.5 | Influence of defect location on absolute bone 
gain: anterior versus posterior
Out of the 29 maxillary vertical defects, 12 were anterior and 17 were 
posterior. The mean baseline vertical deficiency was 5.7 ± 2.7 mm 
anteriorly and 5.1 ± 2.4 mm posteriorly; these values were not sta-
tistically different (p = .489). The mean absolute vertical gain was 
statistically higher in posterior sites than anterior ones by 0.36 mm 
(p = .048) (Table 4). The extent of the baseline vertical deficiency 
(p < .01) and smoking (p < .05) significantly affected maxillary abso-
lute gain (Table 4).
Out of 36 vertical defects, 4 were anterior and 32 were poste-
rior. The mean vertical deficiency was 5.3 ± 1.0 mm anteriorly and 
5.6 ± 2.9 posteriorly; these values were not statistically different 
(p = .540). The mean absolute vertical bone gain was significantly 
greater in anterior sites than posterior ones by 0.32 mm (p = .021) 
(Table 4). The extent of the baseline vertical deficiency and smoking 
significantly affected mandibular absolute gain.
3.6 | Influence of defect location on absolute and 
relative bone gain: anterior versus left posterior 
versus right posterior
In the maxilla, there were 12 anterior, 11 right posterior, and 6 left 
posterior defects. The mean vertical deficiency was 5.5 ± 2.9 mm 
on the right posterior side and 4.3 ± 0.8 on the left posterior side. 
There were no differences in absolute bone gain between maxillary 
left and right posterior sides per multiple linear regression (p = .726). 
Maxillary anterior defects showed less bone gain compared with left 
and right posterior defects (p = .05) (Table 4, Figure 5a).
In the mandible, there were 4 anterior, 15 right posterior, 
and 17 left posterior defects. The mean vertical defect size was 
5.8 ± 3.2 mm on the right posterior side and 5.5 ± 2.6 on the left 
posterior side, with no significant differences between the sides 
(p = .72). A statistically significant difference in vertical bone gain 
was detected between the mandibular anterior, left posterior, and 
right posterior areas (p = .028) (Table 4 and Figure 5b). The rela-
tive vertical gain was 98.3% for mandibular left posterior sites and 
90.9% for right posterior sites (0.3 mm of absolute gain difference).
3.7 | Post- surgical complications
There were only two cases (3%) with complications. One site had 
membrane exposure (at 1 week postoperatively); graft material be-
came infected at a second site. For the first case, the exposed mem-
brane was maintained for 2 months, and then, it was removed. For 
the second case, the infected membrane and graft were explored 
and removed after 10 days of healing.
4  | DISCUSSION
Vertical ridge augmentation using space- making frameworks and graft 
materials offers an ideal balance between the expected amount of 
TA B L E  3   Multiple linear regression analysis on the relative 
vertical gain (%) controlling for defect size, arch, healing time, and 
age
Regression 
coefficient 95% CI p- value
Defect size <.001***
<5 mm (ref.) 0.00
5– 8 mm −5.97 −11.8 to 0.13 .045*
>8 mm −11.9 −17.8 to 5.89 <.001***
Arch
Maxilla (ref.) 0.00
Mandible −2.98 −8.01 to 2.05 .246
Healing time 1.34 0.08 to 2.60 .037*
Age 0.08 −0.05 to 0.21 .207








Percentage of cases with 
complete regeneration (%)
Vertical 5.5 ± 2.6 5.2 ± 2.4 96.5 ± 13.9 89.2
TA B L E  2   Changes of the dimensional 
parameters of the defects after bone 
augmentation
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bone gain and postoperative complications compared with other inter-
ventions (Milinkovic & Cordaro, 2014; Urban et al., 2019). The rationale 
of GBR is based on the creation of a sheltered, soft tissue cell- excluding 
area to promote osteoblast migration (Melcher, 1976). Dimensionally 
stable structures such as titanium- reinforced non- resorbable mem-
branes or non- occlusive titanium meshes support vertical dimensions 
more reliably than cell- occlusive but pliant absorbable membranes. 
Dense polytetrafluoroethylene (dPTFE) is a commonly used non- 
resorbable barrier material, but it may exhibit subpar tissue adhesive 
properties that risk flap integrity (Park et al., 2009). Innovators have 
developed materials that better approximate the periosteum to the 
underlying graft. Our study utilized a titanium- reinforced PTFE mesh 
perforated by macropores that theoretically improves vascularization 
by permitting direct contact between periosteum and bone grafts. 
To our knowledge, this is the first human case series to record use of 
titanium- reinforced PTFE mesh for VBA.
4.1 | Agreement with previous studies
Our case series achieved an absolute vertical bone gain of 
5.2 ± 2.4 mm, which matched results reported in two previous case 
series by author IU using titanium- reinforced dPTFE membranes 
with the same bone graft composition that achieved mean height 
gains of 5.45 and 5.83 mm (Urban et al., 2014, 2015). In the current 
study, we found a relative bone gain of 96.5 ± 13.9% and complete 
vertical ridge regeneration in 89.2% of cases. Compared with results 
from studies by the same author using nonporous dPTFE, titanium- 
reinforced PTFE mesh seems to provide similar or better vertical 
bone gain (Urban et al., 2014, 2015, 2016).
Other studies using titanium- reinforced expanded polytetraflu-
oroethylene membranes (ePTFE) reported similar results to ours. 
Urban et al attained a mean height gain of 5.5 mm using titanium- 
reinforced ePTFE membrane and autologous bone for maxillary and 
F I G U R E  4   (a) Correlation between 
defect size and vertical gain. Red points 
represent cases that were not completely 
regenerated. Five such cases had baseline 
vertical deficiencies measuring ≥10 mm. 
One defect with a baseline deficiency 
of 6 mm showed null gain. (b) Relative 
vertical gain according to baseline 
deficiency
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mandibular, anterior and posterior VBA (staged or simultaneous) 
(Urban et al., 2009). Canullo & Sisti demonstrated a mean height 
gain of 5.85 mm using titanium- reinforced ePTFE membranes with 
magnesium- enriched hydroxyapatite for maxillary and mandibular, 
anterior and posterior VBA (Canullo & Sisti, 2010). Todisco achieved 
a mean vertical height of 5.3 mm using titanium- reinforced ePTFE 
membranes with xenograft (Todisco, 2010). Clinical VBA studies 
using non- resorbable membranes consistently report between 4 and 
6 mm of vertical bone gain (Cucchi et al., 2017; Fontana et al., 2015; 
Ronda et al., 2014; Urban et al., 2019).
Although using space- making frameworks, including meshes 
and GBR membranes, has fewer complications than distraction 
osteogenesis or block grafting, flap dehiscence is a chief concern. 
Absorbable membranes have been associated with more compli-
cations than non- resorbable membranes (Lim et al., 2018). This 
contrast hold trues when VBA- only procedures are considered— 
for these surgeries, absorbable membranes have complication 
rates of 23%, whereas PTFE membranes have rates of 7% (Urban 
et al., 2019). However, not all non- resorbable membranes behave 
similarly. ePTFE membranes present with twice the number of 
the complications that dPTFE barriers do (Urban et al., 2019). Our 
study employing a novel PTFE mesh had a fairly low complication 
rate (3%). Two complications involved membrane exposure at 1 or 
8 weeks post- VBA, which agreed with a previous study reporting 
early and late exposure (as early as 1 week and up to 6 months 
postoperatively) (Lim et al., 2018).
4.2 | Distinctive findings
Most studies investigating VBA report only mean vertical bone gain 
(absolute bone gain) and fail to calculate the relative percentage of 
bone gain with respect to initial defect size. We detected signifi-
cant indirect correlations between baseline vertical deficiency and 
amount of bone gained: as the baseline deficiency increased millim-
eter by millimeter, the probability of having complete regeneration 
decreased by 2.5 times. VBA achieved 6%– 12% greater relative bone 
gain when used for smaller height deficiencies (<5 mm) than larger 
ones (≥5 mm) (Figure 3b).
Ours may be the first VBA study to investigate the effect of de-
fect location on height gain. We did not find significant differences 
between the maxilla and mandible in terms of bone gain. However, 
the location of the defect within either jaw statistically influenced 
the amount of augmentation generated. In the maxilla, absolute 
bone gain was statistically greater in the posterior than the anterior 
area, with a mean difference of 0.36 mm. In contrast, the absolute 
F I G U R E  5   Absolute and relative 
vertical gain in the (a) maxilla and (b) 
mandible
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bone gain in the mandible was statistically greater in the anterior 
than the posterior area, with a mean difference of 0.32 mm. The 
mean height gain differences were <0.5 mm, which may have no 
clinical significance.
4.3 | Limitations and recommendations for 
future research
As our study was a retrospective case series introducing a novel 
space- making mesh, rigorous comparisons to other studies were 
not viable. We postulate that the mesh macropores would en-
hance graft vascularization and therefore improve bone regenera-
tion. Future studies should verify if this assumption is accurate via 
acquiring bone cores at re- entry to confirm regeneration/bone 
viability.
Surgeries were performed by a highly experienced clinician, and 
our outcomes may not be applicable to less seasoned practitioners. 
A prospective clinical trial is needed to compare vertical bone aug-
mentation results using various space- making frameworks, such as 
PTFE mesh and ePTFE, dPTFE. Future comparison should be per-
formed particularly for newer space- maintaining devices such as 
custom titanium mesh and custom- made block grafts. Using a larger 
patient sample with more even distribution would verify or refute 
our findings regarding baseline vertical deficiencies, defect location, 
patient factors, complications, and bone gain. Such analyses will help 
in case preparation and materials selection. Finally, data relative to 
peri- implant bone levels and survival rate after GBR procedure was 
not assessed in the present study. A prospective study will be per-
formed to explore the long- term performance of implants placed in 
vertically augmented bone.
5  | CONCLUSIONS
As the group 4 of the 15th European Workshop on Periodontology 
on Bone Regeneration concluded, vertical ridge augmentation is a 
highly technique sensitive surgical intervention to be performed 
only by highly experienced clinicians (Jepsen et al., 2019).
1. Vertical ridge augmentation with titanium- reinforced PTFE mesh 
and a mixture of autologous bone and xenograft may be a 
safe and predictable procedure.
2. The extent of the baseline vertical deficiency influences the per-
centage of bone augmentation achieved, with each additional mil-
limeter increasing the likelihood of incomplete bone regeneration 
by 2.5 times.
3. The defect location may exert a small influence on the amount of 
bone gained (<0.5 mm).
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